Antibiotic Lock for Treatment of Tunneled Hemodialysis Catheter Bacteremia

被引:7
作者
Maya, Ivan D. [1 ]
机构
[1] Univ Alabama Birmingham, Div Nephrol, Birmingham, AL 35294 USA
关键词
D O I
10.1111/j.1525-139X.2008.00498.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Catheter-related bacteremia is a major cause of morbidity and mortality among catheter-dependent hemodialysis patients. Microorganism biofilm matrix formation in the catheter is the pathogenic process of this entity. Administration of systemic antibiotics and removal of the offending catheter is the most logical treatment. This article discusses an alternative option, instillation of an antibiotic-lock solution into the lumen of the catheter plus systemic antibiotic therapy. Recent studies suggest that this strategy could treat the infection and salvage the catheter, thus avoiding the need for further interventional procedures including but not limited to the removal of the catheter, placement of a temporary catheter, and finally placement of a new permanent catheter. The implementation of this effective approach will reduce morbidity and possibly reduce the cost and interventions associated with it.
引用
收藏
页码:539 / 541
页数:3
相关论文
共 35 条
  • [1] Impact of dialysis dose and membrane on infection-related hospitalization and death: Results of the HEMO study
    Allon, M
    Depner, TA
    Radeva, M
    Bailey, J
    Beddhu, S
    Butterly, D
    Coyne, DW
    Gassman, JJ
    Kaufman, AM
    Kaysen, GA
    Lewis, JA
    Schwab, SJ
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (07): : 1863 - 1870
  • [2] A prospective randomized trial of urokinase as an adjuvant in the treatment of proven Hickman catheter sepsis
    Atkinson, JB
    Chamberlin, K
    Boody, BA
    [J]. JOURNAL OF PEDIATRIC SURGERY, 1998, 33 (05) : 714 - 716
  • [3] Use of vancomycin in high-flux hemodialysis: Experience with 130 courses of therapy
    Barth, RH
    DeVincenzo, N
    [J]. KIDNEY INTERNATIONAL, 1996, 50 (03) : 929 - 936
  • [4] Adjunctive antibiotic/anticoagulant lock therapy in the treatment of bacteremia associated with the use of a subcutaneously implanted hemodialysis access device
    Boorgu, R
    Dubrow, AJ
    Levin, NW
    My, H
    Canaud, BJ
    Lentino, JR
    Wentworth, DW
    Hatch, DA
    Megerman, J
    Prosl, FR
    Gandhi, VC
    Ing, TS
    [J]. ASAIO JOURNAL, 2000, 46 (06) : 767 - 770
  • [5] The Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms
    Ceri, H
    Olson, ME
    Stremick, C
    Read, RR
    Morck, D
    Buret, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) : 1771 - 1776
  • [6] *CTR MED MED SERV, 2004, AM J KIDNEY DIS S, V44, pS1
  • [7] Biofilms: Microbial life on surfaces
    Donlan, RM
    [J]. EMERGING INFECTIOUS DISEASES, 2002, 8 (09) : 881 - 890
  • [8] Biofilm formation: A clinically relevant microbiological process
    Donlan, RM
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) : 1387 - 1392
  • [9] FERNANDEZHIDALG.N, 2002, J ANTIMICROB CHEMOTH, V57, P1172
  • [10] Cefazolin in chronic hemodialysis patients: A safe, effective alternative to vancomycin
    Fogel, MA
    Nussbaum, PB
    Feintzeig, ID
    Hunt, WA
    Gavin, JP
    Kim, RC
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (03) : 401 - 409